← Back
Data updated: Mar 10, 2026
SUNNY
OncologyGastroenterologyImmunology
SUNNY is a generic drug manufacturer focused on Oncology, Gastroenterology, Immunology. Key products include CYCLOPHOSPHAMIDE.
2018
Since
6
Drugs
-
Trials
25
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
PHYTONADIONE 2026-01-09
PHYTONADIONE 2025-11-04
PHYTONADIONE 2025-09-08
AMINOCAPROIC ACID 2025-08-28
CYCLOPHOSPHAMIDE 2025-07-11
Labeling
AMINOCAPROIC ACID 2025-05-19
PHYTONADIONE 2025-04-17
NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS) 2025-03-21
Manufacturing (CMC)
CYCLOPHOSPHAMIDE 2025-03-11
Labeling
PHYTONADIONE 2025-01-03
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 29%
2 drugs
Gastroenterology 29%
2 drugs
Immunology 14%
1 drugs
Respiratory 14%
1 drugs
Infectious Disease 14%
1 drugs
Pipeline Strength Pro
Loading...
Competitors Pro
Pfizer big-pharma
Oncology, Infectious Disease, Immunology, Gastroenterology
GSK big-pharma
Infectious Disease, Respiratory, Oncology, Immunology
Sanofi big-pharma
Oncology, Infectious Disease, Immunology, Respiratory
Gilead Sciences biotech
Infectious Disease, Oncology, Immunology, Gastroenterology, Respiratory
Bristol-Myers Squibb big-pharma
Oncology, Immunology, Gastroenterology, Infectious Disease
Active (5)
Discontinued (1)
Company Info
- First Approval
- 2018-05-24
- Latest
- 2026-01-09
- Applications
- 7